Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$30.17 - $41.11 $54,607 - $74,409
1,810 Added 30.1%
7,823 $282,000
Q4 2022

Feb 14, 2023

BUY
$36.43 - $49.4 $219,053 - $297,042
6,013 New
6,013 $238,000
Q1 2020

May 15, 2020

SELL
$70.23 - $144.31 $140,460 - $288,620
-2,000 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$76.41 - $117.54 $194,081 - $298,551
-2,540 Reduced 55.95%
2,000 $235,000
Q3 2019

Nov 08, 2019

BUY
$61.52 - $91.1 $207,814 - $307,735
3,378 Added 290.71%
4,540 $390,000
Q2 2019

Aug 12, 2019

BUY
$58.04 - $66.99 $67,442 - $77,842
1,162 New
1,162 $75,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.